These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30361434)

  • 1. Hemodynamic Impairment Measured by Positron-Emission Tomography Is Regionally Associated with Decreased Cortical Thickness in Moyamoya Phenomenon.
    Lee JJ; Shimony JS; Jafri H; Zazulia AR; Dacey RG; Zipfel GR; Derdeyn CP
    AJNR Am J Neuroradiol; 2018 Nov; 39(11):2037-2044. PubMed ID: 30361434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hemodynamic impairment on
    Hara S; Tanaka Y; Ueda Y; Abe D; Hayashi S; Inaji M; Maehara T; Ishii K; Nariai T
    J Clin Neurosci; 2020 Feb; 72():258-263. PubMed ID: 31843438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous phase-contrast MRI and PET for noninvasive quantification of cerebral blood flow and reactivity in healthy subjects and patients with cerebrovascular disease.
    Ishii Y; Thamm T; Guo J; Khalighi MM; Wardak M; Holley D; Gandhi H; Park JH; Shen B; Steinberg GK; Chin FT; Zaharchuk G; Fan AP
    J Magn Reson Imaging; 2020 Jan; 51(1):183-194. PubMed ID: 31044459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical thickness changes in adult moyamoya disease assessed by structural magnetic resonance imaging.
    Qiao PG; Zuo ZW; Han C; Zhou J; Zhang HT; Duan L; Qian T; Li GJ
    Clin Imaging; 2017; 46():71-77. PubMed ID: 28734143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral hemodynamics and oxygen metabolism in patients with moyamoya syndrome associated with atherosclerotic steno-occlusive arterial lesions.
    Kato H; Shimosegawa E; Oku N; Kimura Y; Kajimoto K; Tanaka M; Hori M; Kitagawa K; Hatazawa J
    Cerebrovasc Dis; 2008; 26(1):9-15. PubMed ID: 18511866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain temperature measured using proton MR spectroscopy detects cerebral hemodynamic impairment in patients with unilateral chronic major cerebral artery steno-occlusive disease: comparison with positron emission tomography.
    Ishigaki D; Ogasawara K; Yoshioka Y; Chida K; Sasaki M; Fujiwara S; Aso K; Kobayashi M; Yoshida K; Terasaki K; Inoue T; Ogawa A
    Stroke; 2009 Sep; 40(9):3012-6. PubMed ID: 19590051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The leptomeningeal ivy sign on fluid-attenuated inversion recovery images in moyamoya disease: positron emission tomography study.
    Kaku Y; Iihara K; Nakajima N; Kataoka H; Fukushima K; Iida H; Hashimoto N
    Cerebrovasc Dis; 2013; 36(1):19-25. PubMed ID: 23920347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging--comparison with positron emission tomography.
    Tanaka Y; Nariai T; Nagaoka T; Akimoto H; Ishiwata K; Ishii K; Matsushima Y; Ohno K
    J Cereb Blood Flow Metab; 2006 Feb; 26(2):291-300. PubMed ID: 16049427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease.
    Hamano E; Kataoka H; Morita N; Maruyama D; Satow T; Iihara K; Takahashi JC
    J Neurosurg; 2017 Jan; 126(1):1-7. PubMed ID: 26894456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior Infarcts, Reactivity, and Angiography in Moyamoya Disease (PIRAMD): a scoring system for moyamoya severity based on multimodal hemodynamic imaging.
    Ladner TR; Donahue MJ; Arteaga DF; Faraco CC; Roach BA; Davis LT; Jordan LC; Froehler MT; Strother MK
    J Neurosurg; 2017 Feb; 126(2):495-503. PubMed ID: 26967789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central benzodiazepine receptor binding potential and CBF images on SPECT correlate with oxygen extraction fraction images on PET in the cerebral cortex with unilateral major cerebral artery occlusive disease.
    Chida K; Ogasawara K; Kuroda H; Aso K; Kobayashi M; Fujiwara S; Yoshida K; Terasaki K; Ogawa A
    J Nucl Med; 2011 Apr; 52(4):511-8. PubMed ID: 21421729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral hemodynamic change in the child and the adult with moyamoya disease.
    Kuwabara Y; Ichiya Y; Otsuka M; Tahara T; Gunasekera R; Hasuo K; Masuda K; Matsushima T; Fukui M
    Stroke; 1990 Feb; 21(2):272-7. PubMed ID: 2305403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral hemodynamics as a predictor of stroke in adult patients with moyamoya disease: a prospective observational study.
    Zipfel GJ; Sagar J; Miller JP; Videen TO; Grubb RL; Dacey RG; Derdeyn CP
    Neurosurg Focus; 2009 Apr; 26(4):E6. PubMed ID: 19335132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of direct revascularization in adult Moyamoya disease: haemodynamic evaluation by positron emission tomography.
    Morimoto M; Iwama T; Hashimoto N; Kojima A; Hayashida K
    Acta Neurochir (Wien); 1999; 141(4):377-84. PubMed ID: 10352747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vascular responses in cerebrovascular "Moyamoya" disease--evaluated by positron emission tomography].
    Tomura N; Kanno I; Shishido F; Higano S; Fujita H; Inugami A; Tabata K; Uemura K; Sayama I; Yasui N
    No To Shinkei; 1989 Sep; 41(9):895-904. PubMed ID: 2511909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in [18F]-Fluoroacetate Uptake in Patients With Chronic Hemodynamic Cerebral Ischemia.
    Yamauchi H; Kagawa S; Kishibe Y; Takahashi M; Nishii R; Mizuma H; Takahashi K; Onoe H; Higashi T
    Stroke; 2015 Sep; 46(9):2669-72. PubMed ID: 26304865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercapnic BOLD MRI compared to H
    Hauser TK; Seeger A; Bender B; Klose U; Thurow J; Ernemann U; Tatagiba M; Meyer PT; Khan N; Roder C
    Neuroimage Clin; 2019; 22():101713. PubMed ID: 30743136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling Specific Brain Microstructural Damage in Moyamoya Disease Using Diffusion Magnetic Resonance Imaging and Positron Emission Tomography.
    Hara S; Hori M; Ueda R; Hayashi S; Inaji M; Tanaka Y; Maehara T; Ishii K; Aoki S; Nariai T
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1113-1125. PubMed ID: 30679013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic mechanisms underlying elevated oxygen extraction fraction (OEF) in moyamoya and sickle cell anemia patients.
    Watchmaker JM; Juttukonda MR; Davis LT; Scott AO; Faraco CC; Gindville MC; Jordan LC; Cogswell PM; Jefferson AL; Kirshner HS; Donahue MJ
    J Cereb Blood Flow Metab; 2018 Sep; 38(9):1618-1630. PubMed ID: 28029271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial coefficient of variation of arterial spin labeling MRI for detecting hemodynamic disturbances measured with
    Hara S; Tanaka Y; Inaji M; Hayashi S; Ishii K; Nariai T; Maehara T
    Neuroradiology; 2022 Apr; 64(4):675-684. PubMed ID: 34499192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.